Tango Therapeutics had a revenue of 53.81M in the quarter ending Sep 30, 2025, with 1591.64%. This bring the company's revenue in the last twelve months to 66.50M, Decreased 173.70%. In the fiscal year ending Dec 31, 2024, Tango Therapeutics had annual revenue of 42.07M with 15.17% growth.